Detalhe da pesquisa
1.
PCV15, a pneumococcal conjugate vaccine, for the prevention of invasive pneumococcal disease in infants and children.
Expert Rev Vaccines
; 23(1): 137-147, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38111990
2.
A phase 3, single-arm, open-label study to evaluate the safety, tolerability, and immunogenicity of a 15-valent pneumococcal conjugate vaccine, V114, in a 3+1 regimen in healthy infants in South Korea (PNEU-PED-KOR).
Hum Vaccin Immunother
; 20(1): 2321035, 2024 Dec 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38497448
3.
A phase 3, multicenter, randomized, double-blind, active-comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of a 4-dose regimen of V114, a 15-valent pneumococcal conjugate vaccine, in healthy infants (PNEU-PED).
Vaccine
; 41(5): 1142-1152, 2023 01 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36621410
4.
A phase 3, multicenter, randomized, double-blind study to evaluate the interchangeability of V114, a 15-valent pneumococcal conjugate vaccine, and PCV13 with respect to safety, tolerability, and immunogenicity in healthy infants (PNEU-DIRECTION).
Vaccine
; 41(3): 657-665, 2023 01 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36522265
5.
Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in children with SCD: a V114-023 (PNEU-SICKLE) study.
Blood Adv
; 7(3): 414-421, 2023 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36383730
6.
A phase 3 study of safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine, in children with HIV.
AIDS
; 37(8): 1227-1237, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36939067
7.
Safety, tolerability, and immunogenicity of V114 pneumococcal vaccine compared with PCV13 in a 2+1 regimen in healthy infants: A phase III study (PNEU-PED-EU-2).
Vaccine
; 41(15): 2456-2465, 2023 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36841723
8.
Safety and Immunogenicity of V114 in Preterm Infants: A Pooled Analysis of Four Phase Three Studies.
Pediatr Infect Dis J
; 42(11): 1021-1028, 2023 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37566897
9.
A Phase III, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of V114 compared with PCV13 in healthy infants (PNEU-PED-EU-1).
Vaccine
; 41(21): 3387-3398, 2023 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37105892
10.
Safety and Tolerability of V114 Pneumococcal Vaccine in Infants: A Phase 3 Study.
Pediatrics
; 152(1)2023 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37309607
11.
A phase III, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of catch-up vaccination regimens of V114, a 15-valent pneumococcal conjugate vaccine, in healthy infants, children, and adolescents (PNEU-PLAN).
Vaccine
; 40(44): 6315-6325, 2022 10 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36150974
12.
Efficacy and safety of caspofungin in obese patients.
Med Mycol
; 49(7): 748-54, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21466264
13.
Caspofungin use in patients with invasive candidiasis caused by common non-albicans Candida species: review of the caspofungin database.
Antimicrob Agents Chemother
; 54(5): 1864-71, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20231388
14.
Prognostic and predictive value of AJCC-8 staging in the phase III EORTC1325/KEYNOTE-054 trial of pembrolizumab vs placebo in resected high-risk stage III melanoma.
Eur J Cancer
; 116: 148-157, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31200321
15.
Comparison of caspofungin and amphotericin B for invasive candidiasis.
N Engl J Med
; 347(25): 2020-9, 2002 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-12490683
16.
Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia.
N Engl J Med
; 351(14): 1391-402, 2004 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-15459300
17.
Invasive candidiasis treated in the intensive care unit: observations from a randomized clinical trial.
J Crit Care
; 22(3): 237-44, 2007 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17869975
18.
Pharmacoeconomic analysis of caspofungin versus liposomal amphotericin B as empirical antifungal therapy for neutropenic fever.
Am J Health Syst Pharm
; 64(6): 637-43, 2007 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17353573
19.
Sugammadex efficacy for reversal of rocuronium- and vecuronium-induced neuromuscular blockade: A pooled analysis of 26 studies.
J Clin Anesth
; 41: 84-91, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28802619
20.
A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis.
Am J Med
; 113(4): 294-9, 2002 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-12361815